These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Less-than-subtotal parathyroidectomy increases the risk of persistent/recurrent hyperparathyroidism after parathyroidectomy in tertiary hyperparathyroidism after renal transplantation. Triponez F; Kebebew E; Dosseh D; Duh QY; Hazzan M; Noel C; Chertow GM; Wambergue F; Fleury D; Lemaitre V; Proye CA; Clark OH Surgery; 2006 Dec; 140(6):990-7; discussion 997-9. PubMed ID: 17188148 [TBL] [Abstract][Full Text] [Related]
45. [Treatment of secondary hyperparathyroidism resistant to conventional therapy and tertiary hyperparathyroidism with Cinacalcet: an efficiency strategy]. Jean G; Vanel T; Terrat JC; Hurot JM; Lorriaux C; Mayor B; Deleaval P; Vovan C; Chazot C Nephrol Ther; 2010 Apr; 6(2):105-10. PubMed ID: 20185380 [TBL] [Abstract][Full Text] [Related]
46. Increased risk of all-cause mortality and renal graft loss in stable renal transplant recipients with hyperparathyroidism. Pihlstrøm H; Dahle DO; Mjøen G; Pilz S; März W; Abedini S; Holme I; Fellström B; Jardine AG; Holdaas H Transplantation; 2015 Feb; 99(2):351-9. PubMed ID: 25594550 [TBL] [Abstract][Full Text] [Related]
47. [Surgical treatment of secondary and tertiary hyperparathyroidism]. Gasparri G; Camandona M; Mengozzi G; Mullineris B; Raggio E; Vigna S Ann Ital Chir; 2003; 74(4):435-42. PubMed ID: 14971287 [TBL] [Abstract][Full Text] [Related]
48. Bone mineral recovery after parathyroidectomy in patients with primary and renal hyperparathyroidism. Abdelhadi M; Nordenström J J Clin Endocrinol Metab; 1998 Nov; 83(11):3845-51. PubMed ID: 9814456 [TBL] [Abstract][Full Text] [Related]
50. Potential future uses of calcimimetics in patients with chronic kidney disease. Chonchol M; Wüthrich RP NDT Plus; 2008 Jan; 1(Suppl 1):i36-i41. PubMed ID: 25983955 [TBL] [Abstract][Full Text] [Related]
51. The use of cinacalcet after pediatric renal transplantation: an international CERTAIN Registry analysis. Bernardor J; Schmitt CP; Oh J; Sellier-Leclerc AL; Büscher A; Dello Strologo L; Genc G; John U; Weitz M; Zirngibl M; Krupka K; Tönshoff B; Bacchetta J Pediatr Nephrol; 2020 Sep; 35(9):1707-1718. PubMed ID: 32367310 [TBL] [Abstract][Full Text] [Related]
52. Specific genetic aberrations of parathyroid in Chinese patients with tertiary hyperparathyroidism using whole-exome sequencing. Li L; Sheng Q; Zeng H; Li W; Wang Q; Ma G; Xu X; Qiu M; Zhang W; Shan C Front Endocrinol (Lausanne); 2023; 14():1221060. PubMed ID: 37854190 [TBL] [Abstract][Full Text] [Related]
53. Risk of secondary hyperparathyroidism after laparoscopic gastric bypass surgery in obese women. Youssef Y; Richards WO; Sekhar N; Kaiser J; Spagnoli A; Abumrad N; Torquati A Surg Endosc; 2007 Aug; 21(8):1393-6. PubMed ID: 17318692 [TBL] [Abstract][Full Text] [Related]
54. Early persistent hyperparathyroidism post-renal transplantation as a predictor of worse graft function and mortality after transplantation. Isakov O; Ghinea R; Beckerman P; Mor E; Riella LV; Hod T Clin Transplant; 2020 Nov; 34(11):e14085. PubMed ID: 32949044 [TBL] [Abstract][Full Text] [Related]
55. Cholecalciferol supplementation effectively improved tertiary hyperparathyroidism, FGF23 resistance and lowered coronary calcification score: a prospective study. Hu SM; Bai YJ; Li YM; Tao Y; Wang XD; Lin T; Wang LL; Shi YY Endocr Connect; 2022 Aug; 11(8):. PubMed ID: 35904219 [TBL] [Abstract][Full Text] [Related]
56. Low Parathyroid Hormone Guo W; Zhang H; Zhang Y; Huang H; Liu W; Diao Z Front Endocrinol (Lausanne); 2022; 13():869330. PubMed ID: 35634511 [TBL] [Abstract][Full Text] [Related]
58. Pre-Transplant Calcimimetic Use and Dose Information Improves the Accuracy of Prediction of Tertiary Hyperparathyroidism after Kidney Transplantation: A Retrospective Cohort Study. Okada M; Sato T; Himeno T; Hasegawa Y; Futamura K; Hiramitsu T; Ichimori T; Goto N; Narumi S; Watarai Y Transpl Int; 2024; 37():12704. PubMed ID: 38751772 [TBL] [Abstract][Full Text] [Related]
59. [New aspects in the surgical treatment of hyperparathyroidism]. Barth A; Dambacher MA; Bürgi H; Maurer W Schweiz Med Wochenschr; 1987 Apr; 117(15):574-8. PubMed ID: 3296164 [TBL] [Abstract][Full Text] [Related]
60. Influence of Pre-renal Transplant Secondary Hyperparathyroidism on Later Evolution After Transplantation. Garcia-Montemayor V; Sánchez-Agesta M; Agüera ML; Calle Ó; Navarro MD; Rodríguez A; Aljama P Transplant Proc; 2019 Mar; 51(2):344-349. PubMed ID: 30879538 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]